|
CAS No. | 33069-62-4 |
Chemical Name: | Paclitaxel |
Synonyms: | taxal;TAXOL;EMPAC;Onxal;TAXUS;Capxol;NK 105;taxol a;ABI 007;DHP 107 |
CBNumber: | CB3273425 |
Molecular Formula: | C47H51NO14 |
Formula Weight: | 853.91 |
MOL File: | 33069-62-4.mol |
|
|
|
|
Paclitaxel Property |
|
refractive index : |
-49 ° (C=1, MeOH) |
|
|
solubility : |
methanol: 50 mg/mL, clear, colorless
|
|
|
|
|
Stability:: |
Stable. Incompatible with strong oxidizing agents. Combustible. |
|
|
EPA Substance Registry System: |
Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.- hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S, 12aR,12bS)-6,12b-bis(acetyloxy)- 12-(benzoyloxy)-2a,3,4,4a, 5,6,9,10,11,12,12a,12b-dodecahydro- 4,11-dihydroxy-4a,8,13,13- tetramethyl-5-oxo-7,11-methano- 1H-cyclodeca[3,4]benz[1,2- b]oxet-9-yl ester, (.alpha.R,.beta.S)-(33069-62-4) |
|
|
Paclitaxel Chemical Properties,Usage,Production |
Chemical Properties
White Powder |
|
Usage
glucocorticoid, antiinflammatory |
|
Usage
An antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanc
ed forms of Kaposi's sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. |
|
General Description
Needles (from aqueous methanol) or fine white powder. An anti-cancer drug. |
|
Air & Water Reactions
May be sensitive to prolonged exposure to moisture. . |
|
Health Hazard
TOXIC; inhalation, ingestion or skin contact with material may cause severe injury or death. Contact with molten substance may cause severe burns to skin and eyes. Avoid any skin contact. Effects of contact or inhalation may be delayed. Fire may produce irritating, corrosive and/or toxic gases. Runoff from fire control or dilution water may be corrosive and/or toxic and cause pollution. |
|
Fire Hazard
Flash point data for Paclitaxel are not available. Paclitaxel is probably combustible. |
|
Biological Activity
Antitumor agent; promotes and stabilizes tubulin polymerization, causing cell cycle arrest. Induces autocatalytic activation of caspase-10 in CCRF-HSB-2 cells, triggering apoptosis. |
|
|
Paclitaxel Suppliers Global( 387)Suppliers |
Supplier | Tel | Fax | Email | Country | ProdList | Advantage |
Suzhou Pharmaceutical Technology co.,ltd
| 400-000-6498 | 051282177481 | info@fmyykj.com | CHINA |
94
|
61
|
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd
| 010-64430626/13801208576 | 010-64215766 | maggie@chinazhongshuo.com | CHINA |
222
|
65
|
Guangzhou Isun Pharmaceutical Co., Ltd
| 020-39119399 18927568969 | 020-39119999 | isunpharm@qq.com, isunpharm@hotmail.com | CHINA |
4836
|
55
|
BioBioPha Co., Ltd.
| +86-871-65217109 QQ: 1020188433 | +86-871-65215563 | y.liu@mail.biobiopha.com | CHINA |
2997
|
65
|
Kono Chem Co.,Ltd
| 86-29-88770941,81324641 | 86-29-81330164 | sales1@konochemical.com | CHINA |
508
|
55
|
Beijing NuoqiYa Biotechnology Co., Ltd.
| 4000-819-385 010-62329685 13718666987 | 010-62340519 | good@nuoqiya.com | CHINA |
1978
|
55
|
Shanghai Aspire Biological Technology Co., Ltd.
| 021-61317773 | 021-61486878 | sales@aspirebio.com | CHINA |
4812
|
58
|
Shanghai Boyle Chemical Co., Ltd.
| Mr Qiu 86-21-50182298(Domestic Market)Miss Xu 86-21-50180596(Abroad Market) | 86-21-57758967 | sales@boylechem.com | CHINA |
5604
|
55
|
J & K SCIENTIFIC LTD.
| -- | -- | jkinfo@jkchemical.com;market3@jkchemical.com | CHINA |
96847
|
76
|
Meryer (Shanghai) Chemical Technology Co., Ltd.
| +86-(0)21-61259100(Shanghai) +86-(0)755-86170099(ShenZhen) +86-(0)10-59487313(Beijing) | +86-(0)21-61259102(Shanghai) +86-(0)755-86170066(ShenZhen) +86-(0)10-88580358(Beijing) | sh@meryer.com | CHINA |
40407
|
62
|
|
|
|
|
N-BENZYL-BETA-PHENYLISOSERINE ESTER
PACLITAXEL, TAXUS BREVIFOLIA
PACLITAXEL, TAXUS SPECIES
PACLITAXOL
PACLITAXEL
TAXOL(TM)
taxol a
TAXOL EQUIVALENT
TAXOL(R)
TAXOL
taxal
BACCATIN III N-BENZYL-BETA-PHENYLISOSERINE ESTER
BACCATIN III
33069-62-4
BioChemical
Antibiotics
Antibiotics N-S
Antibiotics A to Z
7,11-methano-5h-cyclodeca[3,4]benz[1,2-b]oxete benzenepropanoic acid deriv.
[2ar-[2aalpha,4beta,4abeta,6beta,9alpha(alphar*,betas*),11alpha,12alpha,12bal
-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4
12a-alpha,12b-alpha))-12-alpha
4,10-diacetate2-benzoate13-esterwith(2r,3s)-n-benzoyl-3-phenylisoserine
5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one
-9-ylester
a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca(3,4)benz(1,2-b)oxet-9-y
benzenepropanoicacid,beta-(benzoylamino)-alpha-hydroxy-,6,12b-bis(acetyloxy)
bms181339-01
lester,(2ar-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alpha-r*,beta-s*),11-alph
nsc125973
nsc-125973
oxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydr
oxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca[3,4]benz[1,2-b]oxet
peclitaxel
pha]]-beta-(benzoylamino)-alpha-hydroxybenzenepropanoicacid6,12b-bis(acetyl
Paclitaxe
PACLITAXEL FROM TAXUS BREVIFOLIA
PACLITAXEL FROM TAXUS YANNANENSIS
SEMI-SYMTHETIC PACLITAXEL (NON-CELL- CUL TURE)
PACLITAXEL, 99% NATURAL
PACLITAXEL, RELATED COMPOUND B10-DEACETYL-7-EPIPACLITAXEL, USP STANDARD
PACLITAXEL, 99.5+% NATURAL
PACLITAXEL, 1% PLANT EXTRACT
PACLITAXEL, RELATED COMPOUND ABENZENE PROPANOIC ACID, ALPHA-HYDROXY-BETA-((2-METHYL-1-OXO-2-BUTENYL)AMINO)-, 6,12B-BIS(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-4,11-DIHYDROXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYLC
PACLITAXEL, USP STANDARD
PACLITAXEL, 99% SYNTHETIC
PACLITAXEL, 50% PLANT EXTRACT
Paclitaxel(Taxol)99.5%
C47H51NO14
Paclitaxel, 99+%
Benzenepropanoic acid, b-(benzoylamino)-a-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tet
ramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (aR,bS)-
Paclitaxel Natural
NATURAL PACLITAXEL
SEMI-SYNTHETICAL PACLITAXEL
PACLITAXEL(P)
Paclitaxol(taxol)
Active Pharmaceutical Ingredients
Pharmaceutical material and intermeidates
|